These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10644806)

  • 1. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
    Busch MP; Tobler LH; Tegtmeier G; Polito A; Quan S; Hirschler NV; Dockter J; Giachetti C; Mimms L
    Transfusion; 2000 Jan; 40(1):10-4. PubMed ID: 10644806
    [No Abstract]   [Full Text] [Related]  

  • 2. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
    Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
    J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
    MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
    Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
    Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
    Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation anti-HCV tests predict infectivity.
    Larsen J; Skaug K; Maeland A
    Vox Sang; 1992; 63(1):39-42. PubMed ID: 1384236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management.
    Kiely P; Wilson D
    Transfusion; 2000 May; 40(5):580-4. PubMed ID: 10827263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
    Mison LM; Young IF; O'Donoghue M; Cowley N; Thorlton N; Hyland CA
    Transfusion; 1997 Jan; 37(1):73-8. PubMed ID: 9024493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
    Chaudhary RK; Maclean C
    Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to hepatitis C virus in autologous blood donors.
    Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
    Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.
    Schröter M; Schäfer P; Zöllner B; Polywka S; Laufs R; Feucht HH
    J Med Virol; 2001 Jul; 64(3):320-4. PubMed ID: 11424121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatitis C after liver transplantation. Four serologic tests compared.
    Donegan E; Wright TL; Roberts J; Ascher NL; Lake JR; Neuwald P; Wilber J; Quan S; Kuramoto IK; Dinello RK
    Am J Clin Pathol; 1995 Dec; 104(6):673-9. PubMed ID: 8526212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory.
    Vermeersch P; Van Ranst M; Lagrou K
    J Clin Virol; 2008 Aug; 42(4):394-8. PubMed ID: 18448386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.